1. No category

The 3rd Kuwait International Conference on Head and
Neck Cancer
Provisional Scientific Program
(8th-11th April 2015)
1 St. announcement
Scientific program
Radiodiagnosis:





Dual CT scan: Applications in Head and Neck cancer.
spectrum of thyroid nodules: US and US guided biopsy
Parathyroid imaging: evaluation by ultrasound & 4DCT.
Imaging basics of perineural tumor spread: what to look for.
Imaging evaluation of sino-nasal neoplasia in head and neck
oncology: what to look for?
 Imaging evaluation of neck nodes in: thyroid cancer, treated SCC
and lymphoma patients.
 New imaging modalities in staging of head and neck cancer.
Pathology:
 Molecular diagnosis of thyroid cancer and its impact on patient
management.
 Pathological implications in the management of salivary gland
tumors.
 Melanomas of head and neck: different pathological entities.
 Pathological Alterations in oral cavity cancers.
 HPV in head and neck squamous carcinomas: epidemiology,
molecular and pathologic considerations.
 Pathological aspects of laryngeal tumors.
 Pathological Classification of head and neck sarcomas: Bone, Soft
tissue, Radiation induced sarcoma.
Surgical oncology:
 Risk adapted, evidence based, cost effective treatment of thyroid
cancer.
 Treatment of locally advanced thyroid cancer.
 Central neck dissection in thyroid cancer
 Complications of thyroid surgery: prevention and management.
 Difficult case of advanced thyroid cancer for panel discussion.
 Management of unknown primary cancer.
 Diagnosis and management of primary hyperparathyroidism.
 Re do parathyroid surgery.
 Clinical case scenario for unusually located parathyroid adenoma.
 Tumors of the salivary glands
 Parotidectomy for benign or recurrent parotid tumors: An aesthetic
approach.
 Minor salivary gland cancers: new concepts in the management.
 Impact of resection- margins on tumor recurrence.
 Sentinel Lymph Node Biopsy in Head and Neck Melanoma: indications
and techniques.
 Melanomas of Head & Neck.
 The Role of Surgery and Radiation Therapy in the Management of
Oral Cancer.
 Oncologic evaluation and management of the mandible in oral cavity
cancer.
 Neck node dissection in the management of oral cancer.
 Sentinel node biopsy versus selective node dissection in oral cavity
cancer.
 ENDOSCOPIC RESECTION OF SINONASAL CANCERS:
ONCOLOGIC OUTCOMES.
 Orbital tumors: surgical and reconstructive options.
 Optimal management of Para-pharyngeal Space Tumors.
 Cancer of the middle third of the face.
 Ongoing progress in the surgical management of skull base tumors in
2015.
 MDT Management of nasopharyngeal cancer.
 Surgical salvage of Oropharyngeal Cancer.
 Management of Hypopharyngeal cancer.
 Trans-axillary thoracodorsal artery perforator (TDAP) flap: A
versatile new technique for hypopharyngeal reconstruction.
 Evidence based review of organ preservation strategies in laryngeal
cancer
 Neck dissection techniques and indications.
 THE IMPACT OF PHARYNGEAL CLOSURE TECHNIQUE ON
FISTULA AFTER SALVAGE LARYNGECTOMY.
 Is there still a Role of total laryngectomy in the 21st century?
 Refinement of various flaps in head & neck reconstruction.
 Optimizing the use of Microvascular free fibula flap for mandibular
reconstruction after tumor resection.
 Mandibular reconstruction, new concepts.
 Reconstruction of mandibular osteoradionecrosis ( ORN ).
 Tracheal reconstruction.
 Crico-tracheal resection in the management of tracheal stenosis
and/or cancer invasion.
 The principles of surgical management of head and neck sarcomas.
 The incidence, risk factors and management of local recurrence of
head and neck sarcomas.
Medical oncology and radiotherapy:
 Systemic adjuvant therapy in head and neck melanoma: impact on
prognosis and survival.
 The management of iodine resistant thyroid cancer and the use of
new drugs.
 Current place of IMRT use in head and neck cancer.
 Role of Systemic adjuvant therapy in head and neck melanoma.
 Radiotherapy in oral cancer, what is new.
 Radiation therapy in laryngeal cancer.
 The use of adjuvant radiotherapy in head and neck sarcomas.
 The role of chemotherapy in the preoperative setting, postoperative
(alone or in combination with radiotherapy) and in irresectable
aggressive sarcoma of head and neck.
List of guests of head and neck conference:
Jatin Shah (USA)
Ashok Shaha (USA)
Beth Edeiken (USA)
Ehab Hanna (USA)
Michelle Williams (USA)
Peirong Yu (USA)
Jonathan Irish (Canada)
Patrick Gullane (Canada)
Ralph Gilbert (Canada)
Eugene Yu (Canada)
John Kim (Canada)
Chris Nutting (UK)
Jean-Pierre Jeannon (UK)
Alexis Rapidis (Greece)
Nadia Mokhtar (Egypt)
Ayman Amin (Egypt)
Day 1 : Wednesday 8 April, 2015
09:00 AM - 11:00 AM Opening Ceremony
09:00 AM - 10:00 AM Registration
10:00 AM - 10:05 AM National Anthem
10:05 AM - 10:10 AM Recitation from Holy Quran
10:10 AM - 10:20 AM Minister’s Speech
10:20 AM - 10.30 AM Welcome Speech
10:30 AM - 11:30 AM Break
11:30 AM – 12:00 PM
Keynote Lecture:
Risk adapted, evidence based, cost effective treatment of thyroid cancer
(Jatin Shah, USA)
Session (1): THYROID CANCER
Chairpersons:
1) 03:00PM – 03:20PM Molecular diagnosis of thyroid cancer and its
impact on patient management.
(M. Williams, USA)
2) 03.20 PM – 03.40 The spectrum of thyroid nodules: US and US guided
biopsy (B Edeiken, USA)
3) 3.40 PM – 4.00 PM Treatment of locally advanced thyroid cancer.
(Jatin Shah , USA)
4) 4.00 PM – 4.20 PM Central neck dissection in thyroid cancer
( J. Irish , Canada)
5) 4.20 PM – 4.40 PM Complications of thyroid cancer surgery:
prevention and management. (A. Shaha , USA)
6) 04:40 PM – 05:00 PM A Difficult case of advanced thyroid cancer for
discussion
7) 05:00 PM-05:20PM The management of iodine resistant thyroid cancer
and the use of new drugs.
(C. Nutting UK)
05:20 PM - 05:40 PM
05:40 PM - 06:00PM
Panel Discussion
Break
Session (2): PARATHYROID NEOPLASIA
Chairpersons:
1. 06:00PM-06:20 PM Keynote lecture: Management of unknown primary
(A Shaha, USA)
2. 06:20PM – 06:40 PM Parathyroid imaging: evaluation by ultrasound &
4DCT (B. Edeiken, USA)
3. 06:40PM–07:00PM Diagnosis
and
management
of
primary
hyperparathyroidism.
( A. Shaha, USA)
4. 07:00PM-07:20PM Re-do parathyroid surgery. (A. Amin , Egypt)
5. 07:20PM-07:40PM Imaging evaluation of neck nodes in thyroid cancer,
treated SCC and lymphoma patients. (B. Edeiken, USA)
6. 07:40PM-)8:00PM Clinical case scenario for unusually located
parathyroid adenoma
(Said Marea, Kuwait)
08:00 PM-8:20 PM
08:20 PM-08:45 PM
08:45 PM-10:00 PM
Panel Discussion
Lottery
Dinner
Day 2: Thursday, 9 April, 2015
Session (3): SALIVARY GLANDS TUMOURS
Chairpersons:
1.
10:00AM – 10:20AM Pathological implications in the management of salivary
gland tumors. (M. Williams, USA)
2. 10:20AM – 10:40AM Imaging basics of perineural tumor spread: what to
look for.(Eugene Yu, Canada)
3. 10.40AM- 11.00AM Tumors of the salivary glands (J. Shah, USA)
Parotidectomy for benign or recurrent parotid
tumors: An aesthetic approach. (A. Amin , Egypt)
4. 11:00AM - 11:20AM
5. 11:20AM – 11:40AM Minor salivary gland cancers :new concepts in the
management (P. Gullane, Canada)
6. 11:40 AM – 12:00 PM Current place of IMRT use in head and neck cancer
( C Nutting, UK)
12:00 PM – 12:30 PM
12:30 PM – 03:00 PM
Panel Discussion
Lunch
Session (4): MELANOMAS OF HEAD & NECK
Chairpersons:
1. 03:00PM – 03:20PM
Melanomas of head and neck: different pathological
entities. (M. Williams, USA)
2. 03:20PM – 03:40PM
Melanomas of Head & Neck.
(J. Irish,
Canada).
3. 03:40 PM – 04:00 PM
Role of systemic adjuvant therapy in head
and neck melanoma. ( ????)
4. 04:00 PM – 04:20 PM Impact of resection margins on tumor recurrence.
(J. Irish, Canada)
5. 04:20 PM – 04:40 PM Sentinel Lymph Node Biopsy in Head and Neck
Melanoma: indications and techniques. (J. Irish, Canada)
04:40 PM-05:00 PM
05:00 PM-05:30 PM
Panel Discussion
Break
Session (5): ORAL CAVITY CANCER (SCC)
Chairpersons:
1.
05:30PM – 05:50PM Pathological Alterations in oral cavity cancers.
(N. Mokhtar, Egypt)
2. 05:50PM - 06:10PM The Role of Surgery and Radiation Therapy in the
Management of Oral Cancer. (A. Rapidis, Greece)
3. 06:10PM – 06:30PM Oncologic evaluation and management of the
mandible in oral cavity cancer. (A. Shaha, USA)
4. 06:30 PM – 06:50 PM Neck node dissection in the management of oral
cancer. (A. Rapidis, Greece)
5. 06:50 PM –07:10 PM Role of radiotherapy in oral cancer, what is new?
( John Kim, Canada )
6. 07:10 PM-07:30 PM Sentinel node biopsy versus selective node dissection
in oral cavity cancer. (JP Jeannon, UK)
07:30 PM – 07:50PM
07:50 PM – 08:15 PM
08:15 PM – 10:00 PM
Panel Discussion
Lottery
Gala Dinner (By Invitation)
Day 3 : Friday, 10 April, 2015
Session (6): SKULL BASE, ORBITAL & PARA-PHARYNGEAL
TUMOURS
Chairpersons:
1. 03:00PM – 03:30PM imaging evaluation of sino-nasal neoplasia in head
2.
3.
4.
5.
6.
and neck oncology: what to look for?.
(Eugene Yu, Canada)
03:30PM – 03:50PM Endoscopic resection of sinonasal cancers: oncological
outcome. (E. Hanna, USA)
03:50PM – 04:10PM. Orbital tumors: surgical and reconstructive options.
( A. Rapidis , Greece)
04:10PM – 04:30PM Optimal management of Para-pharyngeal Space
Tumors. (E. Hanna, USA)
04:30PM – 04:50PM
Cancer of the middle third of the face.
( A Rapidis, Greece)
04:50 PM – 05:10 PM Ongoing progress in the surgical management of skull
base tumors in 2015.
(E hanna, USA)
05:10 PM-05:30 PM Panel Discussion.
05:30 PM – 06:00 PM
Break
Session (7): PHARYNGEAL CARCINOMA
Chairpersons:
1-
06:00PM – 06:20PM HPV in head and neck squamous carcinomas:
epidemiology,
molecular
and
pathologic
considerations
(M. Williams, USA)
206:20PM – 06-40 PM New imaging modalities in staging of head and neck
cancer: Dual CT scan applications. (Eugene Yu, Canada)
306:40PM – 07-00 PM MDT Management of nasopharyngeal cancer.
( C Nutting, UK )
407:00PM – 07:20PM
Surgical salvage of oro-pharyngeal cancer
(P Gullane, Canada)
507:20PM – 07:40PM
Management of Hypopharyngeal cancer.
(R Gilbert , Canada)
6- 07:40PM – 08:00PM Trans-axillary thoracodorsal artery perforator
(TDAP) flap: A versatile new technique for hypopharyngeal
reconstruction.
(A. Amin, Egypt)
08:00 PM – 08:15 PM
08:15 PM – 08:45 PM
08:45 PM – 10:00 PM
Panel Discussion
Lottery
Dinner (By Invitation)
Day 4 : Saturday, 11 April, 2015
Session (8): LARYNGEAL CANCER
Chairpersons:
1. 10:00AM-10:20AM
Pathological
aspects
of
laryngeal
tumors.
(N. Mokhtar , Egypt)
2. 10:20 AM – 10:40 AM Evidence based review of organ preservation strategies
in laryngeal cancer (R. Gilbert, Canada)
3. 10:40 AM – 11:00 AM Neck dissection techniques and indications.
(J. Irish, Canada)
4. 11:00 AM – 11:20 AM The impact of pharyngeal closure technique on
fistula after salvage laryngectomy.
( R. Gilbert, Canada)
5. 11:20 AM – 11:40 AM Radiation therapy in laryngeal cancer.
(C. Nutting, UK )
6. 11:40 PM – 12:00 PM Is there still a Role of total laryngectomy in the 21st
century?
(JP Jeannon, UK)
12:00 PM – 12:30 PM
12:00 PM – 03:00 PM
Panel Discussion
Lunch
Session 9: HEAD & NECK RECONSTRUCTION
Chairpersons:
1. 03:00PM – 03:20PM Refinement of various flaps in head & neck
reconstruction (Peirong Yu, USA)
2. 03:20PM – 03:40PM optimizing the use of Microvascular free fibula flap
for mandibular reconstruction after tumor resection. (A. Amin , Egypt)
3. 03:40PM – 04:00PM Mandibular reconstruction, new concepts. (R. Gilbert,
Canada)
4. 04:00 PM – 04:20PM Reconstruction of mandibular osteoradionecrosis
( ORN ). (Peirong Yu, USA)
5. 04:20 PM – 04:40PM Crico-tracheal resection in the management of tracheal
stenosis and/or cancer invasion (P Gullane, Canada)
6. 04:40PM-05:00PM Tracheal reconstruction. (Peirong Yu, USA)
7. 05:00PM -05:20PM Lip reconstruction following ablation for cancer. ( P.
Gullane, Canada)
05:20PM -05:40PM
Panel Discussion
05:40PM-06:00PM
Break
Session 10: Head and neck Sarcomas
Chairpersons:
1. 06:00PM-06:20PM Pathological Classification of head and neck sarcomas:
Bone, Soft tissue, Radiation induced sarcoma.(M. Williams, USA )
2. 06:20PM-06:40PM The principles of surgical management of head and
neck sarcomas.( P. Gullane, Canada)
3. 06:40PM-07:00PM The use of adjuvant radiotherapy in head and neck
sarcomas. ( John Kim, Canada )
The role of chemotherapy in the preoperative setting,
postoperative (alone or in combination with radiotherapy) and in
irresectable aggressive sarcoma of head and neck. ( ?
)
4. 07:00PM-07:20PM
5. 07:20PM- The incidence, risk factors and management of local
recurrences of head and neck sarcomas. ( JP Jeannon, UK )
08:00 PM – 08:15 PM
08:15 PM – 08:45 PM
08:45 PM – 09:00 PM
09:00 PM – 10:30 PM
Panel Discussion.
Closing remarks (Dr.Medhat)
Lottery
Dinner (By Invitation)
DR Medhat Oteifa
Head of the Surgical Oncology Department KCCC
Chairman of the conference organizing committee